SCHEMBL13638703

SCHEMBL13638703

CC1CC=C(S(=O)(=O)NC(=O)Nc2ccc(-n3ccc4cc(NCCN(C)C)ccc4c3=O)cc2)S1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ATM Q13315 18/20 0.34
EPHX2 P34913 1/20 0.32
TERT O14746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12177083 0.90 MEN1 (0.31) ATMTERT
SCHEMBL13638646 0.87 ATM (0.42) ATM
SCHEMBL9922888 0.81 P2RY12 (0.47) ATM
SCHEMBL9922335 0.80 P2RY12 (0.30)
SCHEMBL12177643 0.79 ATM (0.35) ATM
SCHEMBL13638585 0.76 TERT (0.35) ATMTERT
SCHEMBL13638542 0.72 PPARG (0.39)
SCHEMBL9922887 0.71 P2RY12 (0.49)
SCHEMBL12161275 0.71 P2RY12 (0.42)
SCHEMBL14228346 0.71 P2RY12 (0.39) EPHX2TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed